Bio-Quinone Q10

Quick links

Choose a section

Quick links to important sections

Advertisements

Bio-Quinone Q10

Advertisements
Advertisements
Advertisements

Overview of Bio-Quinone Q10

Property Description
Active ingredient Ubiquinone (Coenzyme Q10)
Form Soft-gelatin capsules in oil solution
Pharmacological class Mitochondrial factor, Antioxidant
Common use Energy production support
Origin Natural occurrence (Synthesized for supplementation)

1. Defining Bio-Quinone Q10: Supplement or Medicine?

Bio-Quinone Q10 is formally an Over-The-Counter (OTC) dietary supplement, not a prescribed drug, produced by the manufacturer Pharma Nord. It is provided as soft-gelatin capsules for oral intake and contains the vitamin-like substance known as Coenzyme Q10 (CoQ10). This preparation is manufactured as a standardized preparation to ensure consistent quality. The U.S. Food and Drug Administration (FDA) typically oversees supplements differently than prescription medications, and it has not evaluated CoQ10 preparations for specific medical use.

2. Core Composition and Pharmacological Class (Ubiquinone)

The sole active ingredient [INN] is Ubiquinone, which serves as the chemical name for the oxidized form of Coenzyme Q10. Ubiquinone is a naturally occurring quinone compound essential for life, and it is classified as a bioenergetic enhancer and mitochondrial factor. Ubiquinone functions as an obligatory component in the transfer of electrons within the mitochondria, making it essential for cellular energy processes. Pharmacological studies have supported its designation as an antioxidant that helps protect cell structures.

3. General Purpose and High Bioavailability Formulation

The generalized purpose of supplementing with Ubiquinone is to support overall cellular function and vitality, particularly by facilitating ATP synthesis and acting as an antioxidant. The formulation is delivered in an oil solution within the capsule to dissolve the fat-soluble Ubiquinone. This specialized design is critical for the product's effectiveness, as the bioavailability of Coenzyme Q10 is enhanced when it is delivered dissolved in lipids.

Regulatory References

  1. NIH - Coenzyme Q10 Metabolism
Advertisements

What side effects are possible with Bio-Quinone Q10?

Possible Side Effects and Safety Information

The regulatory documentation for Ubiquinone (Coenzyme Q10) outlines a safety profile generally characterized by low toxicity and a limited range of adverse reactions. The safety classifications provided in official government sources primarily describe these effects as mild and infrequent.


Adverse Reactions and Organ Systems

The most common adverse reactions reported are associated with Gastrointestinal Disorders. These include manifestations such as nausea, diarrhea, stomach pain, heartburn, and vomiting. Other effects documented in the official safety profile are related to the Nervous System Disorders (e.g., headache, fatigue, dizziness) and Skin and Subcutaneous Tissue Disorders (e.g., rash or itching). Additionally, a safety note exists for potential elevated liver function tests (LFTs), which has been observed in the Hepatobiliary Disorders class, particularly at daily amounts of 300 mg or more.


Serious Adverse Reactions and Safety Constraints

While rare, severe allergic reactions constitute a serious adverse reaction tier documented under Immune System Disorders. These reactions can manifest as hives or swelling of the face, lips, or throat. The preparation is contraindicated in individuals with a known hypersensitivity to any of its components.

Official safety statements advise caution for specific populations. Use may be restricted for pregnant women, nursing mothers, and children/adolescents under 18 due to limited safety data in these groups. Caution is also noted for patients with conditions like biliary obstruction. Furthermore, a high-level safety note documents a potential for Ubiquinone to decrease the effectiveness of the anticoagulant warfarin, a consideration explicitly included in regulatory safety summaries.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Ubiquinone (Coenzyme Q10), classified as an Over-The-Counter dietary supplement, is based on a documented low acute toxicity and the absence of a specific severe poisoning syndrome in government regulatory records.

Documented Overdose Scope

Domain Official Regulatory Statement
Documented overdose presentations Manifestations are non-specific and typically limited to high-dose adverse effects, primarily mild gastrointestinal disturbances (e.g., nausea, diarrhea) [NIH - MedlinePlus].
Physiological systems affected Primarily the gastrointestinal system; no severe systemic or life-threatening organ effects are formally documented as an acute overdose syndrome.
Antidote Information No specific antidote is known or formally listed in regulatory documentation for management of over-ingestion.
Emergency-response statements Regulatory guidance mandates that if an excessive amount of the product is ingested, medical advice should be sought from a healthcare professional or poison control center.

Connection to the Overall Overdose Profile

Government regulatory authorities define the overdose profile for Ubiquinone by the absence of a severe, documented clinical toxicity syndrome that would necessitate immediate, specific hospital protocols. Because the documented manifestations are limited to mild, transient effects, the required emergency action is the general mandate of seeking medical advice upon consuming excessive amounts. Management is therefore limited to symptomatic and supportive treatment.

Advertisements

Therapeutic Uses of Bio-Quinone Q10

What Bio-Quinone Q10 Treats: Main Uses and Benefits

Bio-Quinone Q10 is applied across domains where additional symptomatic support is needed, particularly for symptoms linked to organ-specific functional stress or systemic imbalance. It is considered relevant for use as adjunctive support in conditions like chronic heart failure, for managing muscle aches related to statin use, and for providing prophylactic support in recurrent headache patterns.

In clinical settings that involve heightened systemic burden, the supplement is commonly used to help with symptom clusters that may become intense or disruptive. This supportive application is relevant for easing challenging manifestations like pervasive fatigue, low physical energy, and musculoskeletal discomfort. The goal is to assist patients with maintaining functional stability.

It is often used when symptoms intensify and supportive relief is needed, particularly for chronic heart failure, muscle aches, and recurrent headache patterns.

“It contributes to easing discomfort during symptomatic periods and helps maintain a sense of stability when symptoms are more noticeable.”


Quick Fact: Support for Myalgia

Bio-Quinone Q10 is commonly used to help with muscle aches and tenderness in individuals taking statin medications, providing support that helps ease the overall symptom burden linked to medication-induced physiological strain.

Regulatory References

  1. Coenzyme Q10 - StatPearls - NCBI Bookshelf
Advertisements

Eligibility and Restrictions for Use

The official regulatory eligibility for Bio-Quinone Q10 (Ubidecarenone/Coenzyme Q10) is defined primarily by exclusions and cautionary statements issued by government health authorities, reflecting its status as a supplement in many markets.

Eligibility scope

Scope Item Official Regulatory Status
Populations for whom use is contraindicated: Individuals with a known hypersensitivity or allergy to Coenzyme Q10 or any ingredient in the specific product.
Populations for whom use is not recommended: Pregnant women, nursing mothers, and children/adolescents (generally under 18 years) are not recommended consumers due to insufficient data to establish safety.

Eligibility-Related Restrictions

Classification Official Regulatory Status
Age-related eligibility rules: Use in children and adolescents is not established and generally advised against by regulatory bodies.
Condition-specific eligibility rules: Caution is advised for patients with pre-existing conditions such as biliary obstruction or hepatic insufficiency.

Connection to the overall eligibility profile

The regulatory eligibility profile focuses on groups that must be excluded due to known allergy and groups for whom use is not recommended because of an official lack of safety data (such as pregnant women, nursing mothers, and minors). This results in a profile where the general adult population without specific cautionary conditions is considered the appropriate consumer group.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The following interaction patterns for Ubiquinone (Coenzyme Q10) are documented in official regulatory and governmental health authority monographs. This section focuses strictly on documented drug–drug and drug–substance interaction profiles.


Documented Pharmacodynamic and Exposure Interactions

Interacting Substance Category Interaction Classification Outcome Description
Oral Anticoagulants (e.g., Warfarin) Pharmacodynamic Antagonism May decrease the therapeutic effect of the anticoagulant, requiring close monitoring.
Antihypertensive Medicines Additive Pharmacodynamic Effect May result in an increased blood pressure lowering effect when co-administered.
Food (Fat-containing meals) Administration-Timing Interaction Increases systemic exposure and bioavailability of Ubiquinone.

Population and Clearance Restrictions

Ubiquinone is eliminated primarily via the biliary tract. In individuals with hepatic impairment or biliary obstruction, there is a documented potential for the substance to accumulate in the system due to reduced clearance. This is a population-specific constraint noted in regulatory contexts.

No medicinal products are formally classified as absolute contraindications for co-use with Ubiquinone in government prescribing information. The substance is not officially documented as a clinically significant inhibitor or inducer of major CYP-metabolizing enzymes.

Advertisements

Mechanism of Action

Enhancing Cellular Energy Production

Ubiquinone (Coenzyme Q10) functions as a fundamental component of the Mitochondrial Electron Transport Chain (ETC), specifically acting as a crucial electron carrier between Complexes I, II, and III . This role is essential for maintaining the proton gradient across the inner mitochondrial membrane, which directly drives the synthesis of Adenosine Triphosphate (ATP), the cell's main energy source. This mechanism leads to an increase in cellular ATP generation in metabolically active tissues.


Protecting Membranes from Oxidative Stress

The reduced form of CoQ10, Ubiquinol, operates as a lipid-soluble antioxidant integrated within cell membranes. It acts as a free radical scavenger by neutralizing highly Reactive Oxygen Species (ROS), thereby halting the chain reactions that cause lipid peroxidation and damage to cell structures . This mechanism influences cellular redox status and stabilizes the lipid matrix of cell membranes.

Advertisements

Dosage and Administration Information

How to Use Coenzyme Q10 (Bio-Quinone Q10) Supplements

Coenzyme Q10 (CoQ10) is a compound naturally synthesized by the body and is also available as a dietary supplement. Supplementation may be considered as production naturally declines with age or in individuals taking certain medications, such as statins, which can decrease the body's natural CoQ10 levels.

Administration and Dosage

  • Absorption: CoQ10 is a fat-soluble compound, which means it is best absorbed by the body when taken with a meal or snack that contains fat. Taking it with food is widely recommended to enhance bioavailability.
  • Typical Dosing: The common daily dose for general supplementation ranges from 100 mg to 200 mg. For specific health conditions, the dosage may vary widely, ranging from 60 mg to 1,200 mg per day, and is often split into multiple doses throughout the day to maximize absorption and maintain steady levels.
  • Consultation: There is no universally established ideal dose, as individual needs differ. Always follow the specific instructions provided on the supplement packaging or, ideally, seek guidance from a healthcare professional, especially when taking CoQ10 for a specific medical condition or concurrently with prescription medications.

Important Considerations

  • Interactions: CoQ10 may interact with certain medications, including blood-thinning drugs like warfarin, and some blood pressure medications. Always inform your healthcare provider about all supplements you are taking.
  • Onset of Effect: The clinical benefits of CoQ10 supplementation are not immediate. It may take several weeks of consistent use before any noticeable effects are observed.
Condition Typical Daily Dose Range Administration Note
General Supplementation 100 mg - 200 mg Take with food.
Statin-Induced Myalgia 100 mg - 200 mg May help ease muscle discomfort.
Chronic Heart Failure 100 mg - 300 mg Often used as adjunctive therapy.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bio-Quinone Q10

Ubiquinone (Coenzyme Q10) was evaluated in research exploring its application in several clinical settings. The research landscape consists primarily of Randomized Controlled Trials (RCTs) and subsequent Systematic Reviews and Meta-analyses, which are used to evaluate how changes in specific outcomes were measured in research settings under controlled conditions. These studies help show what has been observed so far regarding symptom and outcome patterns.


Evidence for Use in Chronic Heart Failure

This area has been the focus of long-term Randomized Controlled Trials and comprehensive reviews. Researchers examined its application in adults with chronic heart failure, including those with more severe disease conditions marked by functional limitations. The outcomes was studied for included outcomes related to patient survival and rates of outcomes related to heart failure-related hospitalization. Trials also examined outcomes related to physiological strain or stress, such as exercise capacity and levels of certain cardiac stress biomarkers.

Some large, long-term studies reported observed measurements of differences in patient survival rates between the studied groups. Research also describes how study outcomes reflecting daily functioning or activity level were reported over the intermediate to long-term periods of the trials. However, findings were mixed regarding specific physiological measurements, such as sustained changes in heart function markers (like LVEF). This means the evidence quality varies across studies, and certainty remains low for some physiological endpoints.


Evidence for Statin-Associated Muscle Symptoms (SAMS)

Research examined the use of Ubiquinone in patients who reported outcomes related to physical discomfort while taking statin medications. The evidence is derived from short-term Randomized Controlled Trials and their aggregated meta-analyses. Researchers examined patient-reported outcomes describing perceived discomfort, such as the intensity of muscle pain, muscle weakness, and associated fatigue. These studies were conducted during periods of increased symptom activity to assess short-term changes.

Research highlights changes measured during the study period where some trials reported measurements of differences in muscle pain severity scores compared to the placebo group. However, findings were mixed and contradictory across individual trials regarding the observed patterns in discomfort levels. The follow-up durations were limited, typically lasting only a few months, which means long-term effects are not fully established for managing these symptoms over time.


Key Uncertainties and Research Gaps

The available evidence highlights several areas where certainty remains low. The findings were mixed and contradictory across individual trials for several key endpoints. Furthermore, the follow-up durations were limited in many studies, meaning long-term effects are not fully established. Finally, the evidence quality varies across studies due to the use of different CoQ10 formulations and dosages, which introduces variability into the aggregated research results.

Key Studies & References

  1. Coenzyme Q10 - StatPearls - NCBI Bookshelf (General Overview and Indications)
  2. Systematic review and meta-analysis of effectiveness: Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Bio-Quinone Q10 (FAQ)


Q: When is the best time of day to take the dose?

Official product information suggests taking this supplement with a high-fat meal to enhance the absorption of the Coenzyme Q10. The goal is to maximize bioavailability regardless of the specific time of day. Some regulatory-supported information notes that for individuals using higher amounts, taking the dose in the evening has been associated with a potential for mild difficulty with sleep.


Q: How long does it typically take to see the effects of CoQ10 supplementation?

According to studies and official information, the clinical benefits of Coenzyme Q10 are generally not immediate upon starting use. For some health goals, a noticeable effect may not be observed until after several weeks, or in some research up to six months, of use. The time required for any observed changes can vary between individuals.


Q: Are there any specific conditions that would prevent me from taking CoQ10?

The product information indicates that Coenzyme Q10 is not recommended, or is contraindicated, for individuals with a known hypersensitivity or allergy to the active ingredient or any of the capsule components. Caution is specifically advised by regulatory bodies for patients with pre-existing conditions such as biliary obstruction or hepatic insufficiency (issues affecting the liver or bile flow).


Q: What should I do if I miss a dose of Coenzyme Q10?

Official product guidance generally suggests taking a missed dose as soon as it is remembered. If it is nearly time for the next scheduled dose, however, product information advises to skip the missed dose and resume the regular schedule. The directions advise against taking a double or extra dose to compensate for a missed one.


Q: Can I take an extra dose if I feel like I need more energy?

Official product information advises against this practice. Regulatory guidance advises not to take double or extra doses and to strictly follow the recommended dosage listed on the product packaging. It is important to adhere to the dosage instructions provided.


Q: What happens if I accidentally take too much CoQ10?

In the event of accidentally taking too much of this supplement (an overdosage), the official safety information recommends immediate contact with a poison control center or seeking urgent medical help. This guidance is consistent with regulatory standards for all supplements and medicines.

Advertisements

How should Bio-Quinone Q10 be stored and disposed of?

How to Store and Dispose of Bio-Quinone Q10?

Official regulatory documents define specific environmental and safety requirements for the storage and disposal of Bio-Quinone Q10 (Coenzyme Q10).

Storage Constraints

Requirement Official Regulatory Statement
Temperature & Environment Store in a cool, dry place. Keep protected away from direct sunlight.
Containment Keep the container tightly closed when not in use.
Child Protection Keep out of reach of children.

Disposal and Handling

Disposal instructions require compliance with relevant national or regional provisions to ensure safe waste management. If a spill occurs, measures must be taken to keep the substance away from drains, surface, and ground water to prevent environmental contamination. During occupational handling, precautions such as avoiding dust formation and using appropriate protective equipment are required.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bio-Quinone Q10 found in:

A-Z Index: